Manuel Hidalgo Medina, MD, PhD, discusses some of the exciting pancreatic cancer research presented at the 2020 ACCR Virtual Annual Meeting I.
Manuel Hidalgo Medina, MD, PhD
Advertisement
Articles by Manuel Hidalgo Medina, MD, PhD
Manuel Hidalgo Medina, MD, PhD, chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses that rationale for using patient-derived organoids (PDOs) in pancreatic cancer.
Manuel Hidalgo Medina, MD, PhD, discusses microsatellite instability and germline testing patients with pancreatic cancer.
Manuel Hidalgo Medina, MD, PhD, discusses treatment considerations in pancreatic cancer.
Manuel Hidalgo Medina, MD, PhD, discusses the emergence of neoadjuvant chemotherapy and radiation in pancreatic cancer.
Advertisement
Latest Updated Articles
Dr. Hidalgo Medina on Neoadjuvant Therapy in Pancreatic CancerPublished: November 16th 2019 | Updated:
Dr. Hidalgo Medina on Treatment Considerations in Pancreatic CancerPublished: December 5th 2019 | Updated:
Dr. Hidalgo Medina on MSI and Germline Testing in Pancreatic CancerPublished: December 17th 2019 | Updated:
Dr. Hidalgo Medina on the Rationale for Using Patient-Derived Organoids in Pancreatic CancerPublished: May 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL
5